FDA sets out "time to 50%" premarket approval review goals
This article was originally published in Clinica
Executive Summary
The US FDA's new "50%" performance metric pledges to cut the review time for a regular premarket approval (PMA) application to 290 days in fiscal year 2008 and to 330 days for expedited PMAs, according to a detailed explanation released by the agency this week.